Intensity modulated proton therapy planning study for organ at risk sparing in rectal cancer re-irradiation

References

• Guren MG, Kørner H, Pfeffer F, et al. Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993–2010. Acta Oncol. 2015;54(10):1714–1722.
   PubMed Web of Science ®Google Scholar
• Nielsen M, Rasmussen P, Pedersen B, et al. Early and late outcomes of surgery for locally recurrent rectal cancer: a prospective 10-year study in the total mesorectal excision era. Ann Surg Oncol. 2015;22(8):2677–2684.
   PubMed Web of Science ®Google Scholar
• Palmer G, Martling A, Cedermark B, et al. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2007;14(2):447–454.
   PubMed Web of Science ®Google Scholar
• Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006;64(4):1129–1139.
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Lingareddy V, Rakinic J, et al. Reirradiation for rectal cancer and surgical resection after ultra high doses. Int J Radiat Oncol Biol Phys. 1993;27(5):1159–1163.
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Marks GM, Lingareddy V, et al. Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;39(3):643–649.
   PubMed Web of Science ®Google Scholar
• Lingareddy V, Ahmad NR, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;38(4):785–790.
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer. 2002;95(5):1144–1150. 2002.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim CY, Koom WS, et al. Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: a meta-analysis and systematic review. Radiother Oncol. 2019;140:10–19.
   PubMed Web of Science ®Google Scholar
• Guren MG, Undseth C, Rekstad BL, et al. Reirradiation of locally recurrent rectal cancer: a systematic review. Radiother Oncol. 2014;113(2):151–157.
   PubMed Web of Science ®Google Scholar
• Moningi S, Ludmir E, Polamraju P, et al. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clin Transl Radiat Oncol. 2019;19:59–65.
   PubMed Web of Science ®Google Scholar
• Koroulakis A, Molitoris J, Kaiser A, el al. Reirradiation for rectal cancer using pencil beam scanning proton therapy: a single institutional experience. Adv Radiat Oncol . 2021; 6(1):100595.
   PubMedGoogle Scholar
• Berman AT, Both S, Sharkoski T, et al. Proton reirradiation of recurrent rectal cancer: dosimetric comparison, toxicities, and preliminary outcomes. Int J Part Ther. 2014;1(1):2–13.
   Google Scholar
• Gay HA, Barthold HJ, O'Meara E, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012;83(3):e353–e362.
   PubMed Web of Science ®Google Scholar
• Das P, Delclos ME, Skibber JM, et al. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys. 2010;77(1):60–65.
   PubMed Web of Science ®Google Scholar
• Abusaris H, Hoogeman M, Nuyttens J. Re-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region. Technol Cancer Res Treat. 2012;11(6):591–597.
   PubMed Web of Science ®Google Scholar
• Appelt A, Pløen J, Vogelius I, et al. Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(1):74–80.
   PubMed Web of Science ®Google Scholar
• Gort EM, Beukema JC, Matysiak W, et al. Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer. Radiother Oncol. 2021;154:194–200.
   PubMed Web of Science ®Google Scholar